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Table 1. Significant differences between patients with CPA & IPA 
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Cheng2, Kwok-Yung Yuen1,2,3,4, and Patrick Chiu-Yat Woo1,2,,3,4 
1State Key Laboratory of Emerging Infectious Diseases, 2Department of Microbiology, 3Research Centre of Infection and Immunology, 4Carol Yu Centre for Infection, 5Department of 
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Objectives: Chronic pulmonary aspergillosis (CPA) is considered as a “semi-invasive” form of 
pulmonary aspergillosis that occurs in patients with chronic lung disease or mild immunosuppression. 
A major limitation of published studies on CPA is the lack of direct and systematic comparison of the 
characteristics of CPA with those of invasive pulmonary aspergillosis (IPA) in patients from the same 
population over a unified study period. Thus, their comparative epidemiological, clinical, radiological, 
mycological, and prognostic characteristics remain incompletely understood. Misdiagnosis of IPA as 
CPA may occur in patients without classical risk factors, especially critically ill patients in the intensive 
care unit and patients with chronic obstructive pulmonary disease. We therefore conducted this 10-year 
retrospective cohort study to compare the characteristics of CPA with those of IPA in hospitalised 
patients at a tertiary referral center in Hong Kong. 
 
Methods: The case records of hospitalised patients diagnosed with CPA and IPA (using previously 
described diagnostic criteria) at Queen Mary Hospital, Hong Kong, between 1 July 2003 and 30 June 
2013 were reviewed. For IPA, only patients with proven, probable, or probable IPA without prespecified 
radiologic findings were included. Their characteristics and outcome were recorded into a predefined 
database and compared.  
 
Results: A total of 29 and 51 patients with CPA and IPA respectively were included. The CPA group was 
significantly older than the IPA group (p<0.001). Significantly more patients in the CPA group had past 
pulmonary tuberculosis, chronic lung diseases, silicosis, and/or bronchiectasis (p<0.001-0.008). The 
presenting symptoms differed significantly, with the CPA group having weight loss and predominantly 
respiratory symptoms including cough, sputum, and haemoptysis, while the IPA group often had fever 
with minimal respiratory symptoms and weight loss (p<0.001-0.004). The CPA group had higher 
lymphocyte count, haemoglobin level, platelet count, and globulin level, and lower total bilirubin, 
sodium, and urea levels (p<0.001-0.034).  
Fig 1. Kaplan-Meier survival 
curves for CPA and IPA through 
one year after admission 
Results: Cavitary lesion and consolidation/collapse were the most common findings in both CXR and thoracic 
CT scan in the CPA and IPA groups respectively. Only around one-third of the IPA group had the classical 
findings of cavitary lesion, halo and/or air-crescent signs. Fibrosis was more commonly found in the CPA 
group in both CXR and thoracic CT scan (p<0.001). The seropositive rate of anti-Aspergillus antibody was 
significantly higher in the CPA group (p<0.001). Nearly one-tenth of the culture-positive CPA patients had >1 
species isolated from respiratory tract specimens. More patients in the CPA group received antifungal 
treatment (p=0.011). The duration of hospitalisation was significantly shorter in the CPA group (p=0.031). 
Significantly more patients in the IPA group died at one year after admission (p=0.019). 
 
Conclusion: The comparative characteristics of patients with CPA and IPA were identified. The outcome of 
patients with CPA supported the notion that it was a “semi-invasive” form of pulmonary aspergillosis. 
